These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

737 related articles for article (PubMed ID: 23662653)

  • 21. Thrombotic thrombocytopenic purpura in children.
    Loirat C; Coppo P; Veyradier A
    Curr Opin Pediatr; 2013 Apr; 25(2):216-24. PubMed ID: 23422353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case of severe ADAMTS13 deficiency presenting as thrombotic thrombocytopenic purpura in pregnancy.
    Nikolaou M; Karakantza M; Adonakis G; Theodorou G; Zoumbos N; Decavalas G
    Med Pregl; 2012; 65(9-10):436-9. PubMed ID: 23214340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current management and therapeutical perspectives in thrombotic thrombocytopenic purpura.
    Coppo P; Veyradier A
    Presse Med; 2012 Mar; 41(3 Pt 2):e163-76. PubMed ID: 22265954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current insight into thrombotic thrombocytopenic purpura.
    Verbeke L; Delforge M; Dierickx D
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):3-10. PubMed ID: 19851089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. External validation of the PLASMIC score: a clinical prediction tool for thrombotic thrombocytopenic purpura diagnosis and treatment.
    Li A; Khalighi PR; Wu Q; Garcia DA
    J Thromb Haemost; 2018 Jan; 16(1):164-169. PubMed ID: 29064619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acquired Thrombotic Thrombocytopenic Purpura Without Anti-ADAMTS13 Antibody Caused by Influenza A (H1N1) Virus Successfully Treated by Plasma Exchange: A Case Report.
    Kubo K; Abe T; Kawano N; Ochiai H
    Am J Case Rep; 2021 Aug; 22():e932251. PubMed ID: 34334786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic and prognostic values of ADAMTS13 activity measured during daily plasma exchange therapy in patients with acquired thrombotic thrombocytopenic purpura.
    Wu N; Liu J; Yang S; Kellett ET; Cataland SR; Li H; Wu HM
    Transfusion; 2015 Jan; 55(1):18-24. PubMed ID: 24953079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura.
    Zheng XL; Kaufman RM; Goodnough LT; Sadler JE
    Blood; 2004 Jun; 103(11):4043-9. PubMed ID: 14982878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current concepts in thrombotic thrombocytopenic purpura.
    Tsai HM
    Annu Rev Med; 2006; 57():419-36. PubMed ID: 16409158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombotic thrombocytopenic purpura related to severe ADAMTS13 deficiency in children.
    Loirat C; Girma JP; Desconclois C; Coppo P; Veyradier A
    Pediatr Nephrol; 2009 Jan; 24(1):19-29. PubMed ID: 18574602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Defective ADAMTS13 synthesis as a possible consequence of NASH in an obese patient with recurrent thrombotic thrombocytopenic purpura.
    Lombardi AM; Fabris R; Berti de Marinis G; Marson P; Navaglia F; Plebani M; Vettor R; Fabris F
    Eur J Haematol; 2014 Jun; 92(6):497-501. PubMed ID: 24460705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ADAMTS13 and anti-ADAMTS13 autoantibodies in thrombotic thrombocytopenic purpura - current perspectives and new treatment strategies.
    Tersteeg C; Verhenne S; Roose E; Schelpe AS; Deckmyn H; De Meyer SF; Vanhoorelbeke K
    Expert Rev Hematol; 2016; 9(2):209-21. PubMed ID: 26581428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombotic thrombocytopenic purpura: a moving target.
    Sadler JE
    Hematology Am Soc Hematol Educ Program; 2006; ():415-20. PubMed ID: 17124092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombotic thrombocytopenic purpura-what is new?
    Shah N; Sarode R
    J Clin Apher; 2013 Feb; 28(1):30-5. PubMed ID: 23420593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on thrombotic thrombocytopenic purpura.
    Osborn JD; Rodgers GM
    Clin Adv Hematol Oncol; 2011 Jul; 9(7):531-6. PubMed ID: 22402460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spontaneous recovery in a patient with acquired thrombotic thrombocytopenic purpura (TTP): observation of a 'subclinical' TTP state.
    Browning S; Bahar B; Lee AI; Gorshein E
    Hematology; 2020 Dec; 25(1):473-477. PubMed ID: 33269995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombotic thrombocytopenic purpura: from diagnosis to therapy.
    Mariotte E; Veyradier A
    Curr Opin Crit Care; 2015 Dec; 21(6):593-601. PubMed ID: 26418759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advantages and limits of ADAMTS13 testing in the prognostic assessment of thrombotic thrombocytopenic purpura.
    Mannucci PM; Franchini M
    Presse Med; 2012 Mar; 41(3 Pt 2):e157-62. PubMed ID: 22244722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immature platelet dynamics correlate with ADAMTS13 deficiency and predict therapy response in immune-mediated thrombotic thrombocytopenic purpura.
    Zhu ML; Reeves HM; Maitta RW
    Thromb Res; 2021 Feb; 198():72-78. PubMed ID: 33290885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand.
    Fox LC; Cohney SJ; Kausman JY; Shortt J; Hughes PD; Wood EM; Isbel NM; de Malmanche T; Durkan A; Hissaria P; Blombery P; Barbour TD
    Nephrology (Carlton); 2018 Jun; 23(6):507-517. PubMed ID: 29419916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.